CORT - CORCEPT THERAPEUTICS INC
33.87
-0.170 -0.502%
Share volume: 1,202,725
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$34.04
-0.17
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-29-2024 | 10-30-2024 | 02-26-2025 | 05-05-2025 | 07-31-2025 | 11-04-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 655.935 M | 714.555 M | 784.257 M | 840.553 M | 846.455 M | 801.722 M | 823.607 M | 836.651 M | |
| Current Assets | 503.367 M | 560.846 M | 466.978 M | 471.602 M | 438.503 M | 443.112 M | 541.130 M | 485.464 M | |
| Inventories | 7.190 M | 8.350 M | 8.050 M | 12.412 M | 14.368 M | 12.276 M | 12.349 M | 12.868 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 261.011 M | 344.568 M | 243.047 M | 255.669 M | 232.944 M | 239.481 M | 296.545 M | 251.657 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 149.750 M | 128.588 M | 137.289 M | 127.665 M | 89.819 M | 102.745 M | 125.138 M | 120.495 M | |
| Total Non-current Assets | 40.276 M | 19.315 M | 167.310 M | 219.831 M | 248.041 M | 172.775 M | 102.557 M | 160.270 M | |
| Property Plant Equipment | 127.000 K | 1.472 M | 2.930 M | 2.689 M | 2.543 M | 2.348 M | 2.094 M | 1.890 M | |
| Other Assets | 152.441 M | 152.237 M | 314.349 M | 366.262 M | 405.409 M | 356.262 M | 280.383 M | 349.297 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 655.935 M | 714.555 M | 784.257 M | 840.553 M | 846.455 M | 801.722 M | 823.607 M | 836.651 M | |
| Total liabilities | 108.071 M | 118.312 M | 145.422 M | 160.964 M | 163.170 M | 165.929 M | 191.705 M | 188.846 M | |
| Total current liabilities | 97.202 M | 100.750 M | 126.216 M | 140.773 M | 143.066 M | 144.664 M | 172.265 M | 166.085 M | |
| Accounts Payable | 12.557 M | 19.484 M | 18.584 M | 15.376 M | 27.947 M | 23.525 M | 34.446 M | 40.444 M | |
| Other liabilities | 0.000 | 5.625 M | 6.359 M | 6.107 M | 5.851 M | 5.588 M | 5.308 M | 7.585 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 5.625 M | 6.359 M | 6.107 M | 5.851 M | 5.588 M | 5.308 M | 7.585 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 547.864 M | 596.243 M | 638.835 M | 679.589 M | 683.285 M | 635.793 M | 631.902 M | 647.805 M | |
| Common stock | 758.377 M | 781.146 M | 806.452 M | 832.244 M | 863.003 M | 901.002 M | 933.752 M | 968.740 M | |
| Retained earnings | 430.288 M | 465.776 M | 512.989 M | 543.735 M | 564.282 M | 599.431 M | 619.099 M | 643.387 M |